医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.

广告
第一作者: Cory,Perugino
第一单位: Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
作者单位: Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. [1] Translational Gastroenterology Unit, John Radcliffe Hospital, and Nuffield Department of Medicine, University of Oxford, Oxford, UK. [2] Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, USA. [3] Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, Beijing, China. [4] Unit of Immunology, Rheumatology, Allergy, and Rare Diseases (UnIRAR), San Raffaele Hospital, Milan, Italy. [5] Department of Internal Medicine, Kansai Medical University Kori Hospital, Osaka, Japan. [6] The First Department of Internal Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. [7] Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden. [8] Département de Medecine Interne, CHU Timone, AP-HM, Aix-Marseille Université, Marseille, France. [9] Horizon Therapeutics, Rockville, MD, USA. [10] Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA. jhstone@mgh.harvard.edu.;Rheumatology Unit, Massachusetts General Hospital, 55 Fruit Street, Suite Yawkey 4, Boston, MA, 02114, USA. jhstone@mgh.harvard.edu. [11]
DOI 10.1007/s40744-023-00593-7
PMID 37792260
发布时间 2024-10-13
提交
  • 浏览0
Rheumatology and therapy

Rheumatology and therapy

2023年10卷6期

1795-1808页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷